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With the advent of therapeutic hypothermia for the treatment of hypoxic-ischemic 
encephalopathy, a new era of neuroprotection has begun for the care of the newborn 
with brain injury. Implementing such treatments requires a multi-disciplinary approach to 
“brain focused care.” The Neurointensive Care Nursery (NICN) is a model of co-
management of the at- risk newborn by a team comprising neurologists, neonatologists, 
and specialized nurses. Development of standardized protocols has optimized 
consistency of care and establishment of best practices. Central to treatment of these 
newborns is the availability of neuro-monitoring around the clock, including video EEG 
monitoring, aEEG monitoring, and state of the art MRI that provide a basis for rapid 
diagnosis and stratified treatment. Specialized nurses are critical to evaluate and 
properly triage newborns as a part of optimized care. Given progress in understanding 
evolution of brain injury, the impact of neonatal seizures, and the benefit of appropriate 
interventions, the NICN becomes indispensible in adopting new standards of care as 
well as a platform for research and further dissemination of knowledge. We envisage 
that the NICN of the future will incorporate novel technologies (e.g., whole genome 
diagnostics) and systems to capture long-term outcomes and demonstrate enduring 




Origins and Principles of Neonatal Neurocritical Care 
 
 
Neurocritical care is an established subspecialty that combines expertise in neurology 
and critical care medicine. It is the intensive care provided for adults and children with 
severe neurological or neurosurgical conditions and combines specialized neurological 
monitoring and clinical expertise, as well as a culture shift for an intensive care unit (ICU) 
toward “brain-focused care.” Therefore, all providers are continually aware of the 
potential neurological complications of critical illnesses and how their management may 
be influencing the brain.1-3 This culture shift can be achieved through education and 
development of specialized teams that work together using common management 
guidelines. In neonates, the team must pay particular attention to the impact of critical 
illnesses and management strategies on the developing brain, arguing for a 
comprehensive team approach that involves intensivists, developmental clinicians and 
even basic scientists.  
The goal of neurocritical care is to minimize the impact of the initial insult or underlying 
condition through supportive and interventional clinical management to prevent ongoing 
or secondary brain injury, implement neuroprotective strategies and minimize adverse 
neurological outcomes after a primary insult such as traumatic brain injury, ischemic 
stroke, intracranial hemorrhage and global hypoxia.1 The neurocritical care approach 
involves routine management of physiology (temperature, blood pressure, glycemia, 
among others), combined with intensive monitoring of brain activity through continuous 
electroencephalogram (EEG) and, in neonates, adapted monitors such as amplitude-
integrated EEG (aEEG), monitoring intracranial pressure and autoregulation through 
invasive monitors in adults and children, as well as proxy measures such as near 
infrared spectroscopy (NIRS) and continuous invasive blood pressure monitoring in 
neonates, as well as detailed brain imaging using MRI to determine diagnosis, extent of 
injury and prognosis.  
Neurocritical care in adults has proven benefit4,5 While there is less evidence in 
neonates, this vulnerable group should in principle also benefit from optimizations 
inherent in a focused neurocritical care approach, e.g., through recognition of 
neurological conditions, prevention of secondary brain injury, rapid identification and 
treatment of neurological complications such as seizures, consistent management using 
guidelines and protocols, careful consideration of gestational age and appropriate 
developmental care, the use of optimized teams at dedicated referral centers, and 
research. Specifically, a specialized neonatal neurocritical care service can offer the 
following brain care measures: rapid implementation of therapeutic hypothermia and 
other neuroprotective strategies by an experienced team, around-the-clock detection 
and standardized treatment of seizures with continuous brain monitoring, high quality 
brain MR imaging, and parent counseling by experienced physicians and nurses. 
The neonatal neurocritical care approach starts at the time a neurological condition (or 
high risk for a neurological condition) is recognized and does not end until the family has 
been appropriately counseled about diagnosis and prognosis, and child has been 
referred for intervention services and follow-up for careful developmental monitoring to 
mitigate the longterm effects of early brain injury.  
Conditions Treated by a Neonatal Neurocritical Care Service. Unlike adults, the majority 
of neonates that are evaluated by a neurocritical care service have a primary medical 
diagnosis as the reason for admission, including complications of prematurity and 
congenital heard malformation.6,7 The most common conditions treated within a neonatal 
neurocritical care service are encephalopathy and seizures, usually due to global 
hypoxic-ischemic injury, focal arterial and venous infarcts, intracranial hemorrhage and 
infection.6,8  
 
Development of a Neurointensive Care Nursery (NICN) 
Over the past decade, neurointensive care nurseries and neonatal neurocritical care 
services have opened at a number of centers. They are also an exciting paradigm shift 
in neonatal intensive care with the potential to influence how all neonates at risk for brain 
injury receive care.  They represent a well-coordinated, multidisciplinary approach to 
“brain focused care,” but require a considerable assembly of clinical expertise and 
commitment of institutional resources.  
Neonatal Neurocritical Care patients can range from well appearing babies with only 
subclinical symptoms to profoundly ill neonates with multisystem organ dysfunction. But 
unlike adult and pediatric neurocritical care patient populations, half of NICN patients are 
admitted for medical issues other than a primary neurological disorder, placing greater 
emphasis on the care of the baby as a whole.6,7 Co-morbidities may include 
hemodynamic collapse, electrolytes and metabolic derangements, coagulopathy, 
systemic and CNS infection, and cardiorespiratory failure requiring extracorporeal life 
support (ECLS/ECMO).9 Thus, many Neonatal Neurocritical Care Programs are in high-
acuity NICU settings at larger tertiary care hospitals with pediatric surgical and 
subspecialty support; and often Centers of Excellence in pediatric neurologic care. We 
describe the evolution of the first NICN at University of California at San Francisco 
(UCSF) in April 2008 as a road map for the development of NICN Programs.  
Initial Planning and Program Proposal  
In the spring of 2007, leaders from the Divisions of Neonatology and Pediatric Neurology 
at UCSF committed to develop a model of co-managed care to leverage emerging 
advances in neuromonitoring, neuroimaging, treatment and prevention to improve 
outcomes for neonates at risk for brain injury. Stakeholders from neonatology, child 
neurology, neonatal nursing, neurophysiology/epileptology, neuroradiology, 
developmental and follow-up care convened several planning meetings. These 
discussions helped identify the core leadership group as well as the services and 
protocols required to support an interdisciplinary neonatal neurocritical care service. The 
specific aim of the Program was to improve neurodevelopmental outcomes in newborns 
at risk of neurological disability. A proposal for strategic support was submitted to the 
UCSF Medical Center as well as philanthropic organizations for initial funding and the 
Neurointensive Care Nursery (NICN) at UCSF opened in July 2008. 
 
Building the team 
A key step in development of the NICN model of care was the addition of a dedicated 
neonatal neurologist to help “co-manage” babies with the neonatologist. This was a 
significant staffing commitment by the Department of Neurology, but changed the role of 
the neurologist from occasional consultant to an active member of the neonatal critical 
care team. The neurologist could now be involved in the care of the baby from the point 
of admission or initial diagnosis of a neurologic problem through to discharge. This 
brought a full-time neurological perspective to the ICN team to help perform 
comprehensive neuro evaluations and exams, facilitate diagnosis and management of 
seizures, interpret neuroimaging and neuromonitoring data, discuss prognosis with 
families, and provide continuity of care after discharge from the intensive care nursery. 
This is supported by evidence that having a dedicated neonatal neurologist partner with 
the team at a tertiary care NICU can result in a greater number of neurology consults 
with a wider variety of diagnoses.10 
 
Another essential component of the NICN was commitment from neonatal nursing, 
including a cohort of specially trained NICN nurses. All ICN nurses received some 
additional NICN training as part of Annual Review. But a cohort of nurses with interest in 
NICN care volunteered to completed additional training on common neurologic 
conditions affecting neonates, with a focus on pathophysiology, clinical presentation, 
diagnostic tests, treatment protocols and integration of neurologic monitoring into daily 
bedside care. Special competency-based training modules were also created to maintain 
and verify nursing skills. Once an adequate cohort was trained, two (2) NICN nurses 
were scheduled each nursing shift to respond to neurologic emergencies, ensure NICN 
protocols were appropriately followed, and act as a resource for brain-focused care to 
other nursing colleagues. NICN nurses play a critical role at the bedside with the ability 
to recognize acute changes in neurologic status, then rapidly implement appropriate 
protocols or continue to monitor patients to prevent secondary injury.11  
 
The role of NICN Director was shared between a neonatologist and neonatal 
neurologist. Other dedicated NICN specific roles included a NICN Program Coordinator 
and Nurse Educator. Existing services used frequently by the NICN but shared with 
other services included neuroimaging (US, MRI) and neurophysiology/epileptology 
(vEEG). Other services shared with the ICN included pharmacy, nutrition, OT/PT, child 
life, social work, spiritual and palliative care, and developmental specialists from the 
Newborn Individualized Developmental Care and Assessment Program (NIDCAP). All 
were considered stakeholders and were invited to participate in weekly NICN working 
group meetings.   
 
Organizational Structure and Provider Guidelines 
A core principle of the NICN program is a multidisciplinary approach to care (Figure 1).  
  
Figure 1. Organizational Structure of the NICN 
 
A working group of the various stakeholders met weekly to identify important clinical 
workflows and help develop clinical practice guidelines and protocols related to the NICN 
population. In addition to neonatology, neonatal neurology and neonatal nursing, the 
working group included neurophysiology/epilepsy, neuroimaging, neurosurgery, 
developmental care, PT/OT, nutrition, social work, case management and high-risk 
infant follow-up.12 The working group identified key practices related to NICN workflows, 
which were then developed into evidence-based guidelines and protocols (Table 1). 
Table 1. NICN Provider Guidelines & Protocols  
 NICN/ICN Co-management Guidelines 
 Neonatal Neurologic Exam  
 Neurologic Care for the ‘At-Risk’ Newborn  
 Therapeutic Hypothermia Protocol (Inborn Babies) 
 Therapeutic Hypothermia Protocol (Outborn Babies) 
 Therapeutic Hypothermia and FEN Management 
 Therapeutic Hypothermia and Pulmonary Hypertension 
 Therapeutic Hypothermia and ECMO 
 Therapeutic Hypothermia Transport Guidelines 
 Therapeutic Hypothermia Early Exit Guidelines 
 Late Identification of Encephalopathy and HIE 
 Seizure management 
 Triage System for EEG Interpretation  
 Stroke Management Guidelines 
 Post Hemorrhagic Hydrocephalus Guidelines 
 Myelomeningocoele Patient Care Guidelines 
 Conventional (cEEG) Monitoring Guidelines 
 Amplitude-integrated (aEEG) Monitoring Guidelines 
 EEG Interpretation 
 NIRS Monitoring Guidelines 
 NICN Evaluation in Cardiac Patients  
 MRI Ordering of Study Scans 
 MRI Evaluation in Cardiac Patients 
 Guidelines for Preterm Newborn Imaging  
 Guidelines for Preterm Newborn Monitoring  
 NICN Discharge planning 
 Pediatric Brain Death Determination 
 
Protocol guided care 
Protocol guided care brings consistency of approach to the management of NICN 
patients. Standardization also improves our ability to conduct meaningful clinical 
investigations by minimizing variability in this high-acuity population of patients. 
Protocols and practice guidelines were incorporated into provider training, nursing 
competencies and Annual Review for NICN nurses. They were also disseminated to 
affiliated delivery hospitals through the Neonatal Outreach Education Program, as well 
as by regional collaborative workshops. Working together through regional 
collaboratives, protocols were shared and contributed to the development of a California 
Statewide HIE screening campaign,13 as well as the adoption of California Statewide 
standards for programs providing therapeutic hypothermia to neonates.14,15 
 
New provider guidelines and protocols are created while existing guidelines are 
continuously updated after practice-based feedback discussed during NICN leadership 
group meetings. The NICN leadership group also supports ongoing clinical research 
projects, develops education and training programs, monitors programmatic outcomes 
and quality improvement, provides peer-support for staff and conducts outreach 





The Evidence for Neonatal Neurocritical Care 
There is increasing evidence that an NICN approach can improve care for neonates with 
neurological conditions. 
Availability of a Neonatal Neurologist. Most published reports of neonatal neurocritical 
care programs include involvement of a neurologist with special expertise in neonatal 
neurology.6,7,10,12,16 Mulkey and Swearingen specifically evaluated the impact of having a 
dedicated neonatal neurologist at a single neonatal intensive care nursery. When 
comparing the period post-neonatal neurologist to the period pre-neonatal neurologist, 
there were twice the number of consultations and twice the number of visits per patient 
as well as increased use of video-EEG and a larger variety in types of patients 
evaluated.10  
Neuromonitoring. The utilization of neuromonitoring using continuous prolonged video-
EEG studies within the neuro-intensive care nursery varies widely with reported rates 
between 35-67%, 6,7,10 which may depend on use of American Clinical Neurophysiology 
Society guidelines for monitoring or the definition of what constitutes a NICN patient.17 
Several studies show a positive impact of increased use of video-EEG within a neonatal 
neurocritical care program. Wietstock et al evaluated the yield of continuous video-EEG 
and showed that electrographic seizures were captured in 26% (with 24% of those 
having seizures with no clinical correlate) and in 13%, clinical seizures were suspected 
but ruled out based on normal video-EEG monitoring.18 The same group showed a 
substantial decrease in the use of phenobarbital (on average 30mg/kg less) for neonates 
with encephalopathy and seizures after implementation of continuous video-EEG 
throughout the period of therapeutic hypothermia and rewarming and within the context 
of an NICN,19 as well as increased detection of EEG seizures without clinical correlate.20 
Bashir et al similarly evaluated the use of continuous video-EEG within the context of a 
neurocritical care service and also found improved EEG seizure detection, decreased 
overall phenobarbital doses and reduced use of anti-seizure medication at the time of 
discharge home.16 
Treatment Pathways. Harris et al describe a treatment algorithm for neonatal status 
epilepticus that was developed and endorsed by neonatologists, neurologists and 
pharmacists.21 They describe an estimated absolute reduction in seizures progressing to 
status epilepticus of 10%, as well as a decreased length of stay after implementation of 
the algorithm. Limitations of the study include small sample size, lack of randomization 
and limited statistical analysis, nonetheless, it demonstrates that treatment algorithms 
may improve seizure treatment.  
Preventing Brain injury 
Intraventricular Hemorrhage (IVH) Prevention Bundles. IVH and periventricular 
hemorrhagic infarction (PVHI) are common complications of premature birth and are 
associated with adverse neurodevelopmental outcomes.22 “IVH prevention bundles” 
have emerged in the qualitative literature as important tools for reducing morbidity 
associated with IVH. Measures include delayed cord clamping, minimizing handling, 
midline head positioning, limiting infusion rates, and frequent multidisciplinary 
assessments.23-25  
 
Infection. Preventing hospital-acquired infection is an important measure of quality of 
care. Infection acquired in the neurocritical care unit has been addressed in the adult 
literature.26 The topic of infection control in the neonatal NICN is particularly important 
given the relationship between sepsis and necrotizing enterocolitis and brain injury (and 
particularly white matter injury) and developmental outcome in preterm neonates.27,28 
 
Preventing Secondary Brain Injury. Preventing secondary injury has played an important 
role in adult neurocritical care and there is increasing evidence that attention to basic 
physiology is also important for neonates with brain injury. Optimizing brain metabolic 
environment and perfusion are the focus of secondary injury prevention. The neonatal 
neurocritical care service has a role to play to monitor and manage temperature, carbon 
dioxide and glucose, as well as oxygenation and blood pressure (Table 2). 
Temperature. Targeted temperature management (TTM) is often used in the 
neurocritical care unit to minimize secondary brain injury after trauma, hypoxia-ischemia, 
stroke and hemorrhage, and can lead to improved outcomes, with the strongest 
evidence for adult cardiac arrest and neonatal hypoxic-ischemic encephalopathy.29,30 
TTM can include therapeutic hypothermia, active normothermia and fever treatment. A 
primary mechanism by which TTM can prevent secondary brain injury is by reducing 
metabolic demand (and thereby reducing processes that can be regulated by metabolic 
rate such as inflammation and free radical production). 
Therapeutic hypothermia for neonatal encephalopathy presumed due to hypoxia-
ischemia has been standard of care for almost a decade, with evidence for reduced 
death and disability at 18-22 months, as well as higher rates of normal outcome and 
lower rates of death and disability persisting until school age.31,32 Wyatt et al reported 
that neonates enrolled in the CoolCap trial who had temperatures at least 38oC had a 
higher risk of death and disability, even among those who received cooling and, 
therefore, prevention of pyrexia is paramount.33  
 
Ventilation. Cerebral perfusion is related to CO2 such that hypocapnia can lead to 
vasoconstriction and reduced cerebral blood flow. Secondary analyses of large 
randomized controlled trials of hypothermia show higher rate of death and disability 
among neonates with lower CO2 in the first 72 hours or increased cumulative exposure 
to hypocarbia.34,35 The results held true for both moderate and severe encephalopathy 
as well as after adjusting for pH, amplitude-integrated electroencephalogram 
background and seizures, birth weight, Apgar at 5 min, and cooling status.34 
Glucose management. Although neonates typically tolerate lower glucose values than 
older children or adults, hypoglycemia can cause de novo brain injury in neonates.36 A 
secondary analysis of CoolCap study showed that neonates with normal glucose 
measures had the lowest rates of death and disability, as compared to those with 
hypoglycemia (highest rate of death or disability) and hyperglycemia (intermediate).37 
Tam et al reported an increased risk of brain injury and adverse neurodevelopmental 
outcome in neonates at risk for encephalopathy who had hypoglycemia within the first 24 
hours after birth.38 The role of active glucose management, especially for hyperglycemia, 
is uncertain, although carefully monitoring and minimizing both hypoglycemia and 
fluctuations glucose levels in the brain injured patient is probably warranted.  
Oxygenation and blood pressure management have been extensively studied in preterm 
neonates, particularly during the first “golden hour” after birth.25 Both high and low 
oxygen saturation can have toxic effects. A Cochrane review of the major trials of 
oxygen management during hospitalization concluded a higher rate of death with lower 
target oxygen saturation (85-89%) and higher rate of retinopathy of prematurity with 
higher target oxygen saturation (90-95%).39 Adequate blood pressure is required to 
maintain brain perfusion; low blood pressure and rapid infusions have been linked to 
intraventricular hemorrhage.40 The role of PDA in regulation of CBF in the preterm infant 
is uncertain. Together, these studies suggest that close attention to and management of 
basic physiologic measures are important to neonatal brain health, however well 
designed studies of management pathways are needed to definitively determine whether 
active management to maintain normal physiologic values can impact outcome.  
Table 1: Brain focused care to prevent secondary brain injury 
Parameter Approach 
Temperature  Targeted temperature management: 
o Implement hypothermia as indicated for 
neonatal encephalopathy due to hypoxia-
ischemia 
o Maintain normothermia if hypothermia is not 
indicated 
o Treat fever 
Ventilation  Maintain normal CO2 and avoid hypocapnia 
Glucose  Maintain normoglycemia: avoid both hypo and 
hyperglycemia 
Blood pressure  Maintain normal blood pressure  
 Cerebral autoregulation may be impaired 
 
Developmental care. Preterm neonates <37 weeks gestational age at birth are at very 
high risk for long term motor, cognitive and behavioral problems, even in children without 
acute brain injury. The role of developmental care interventions (e.g. kangaroo care, 
various parent involvement programs, newborn individualized developmental care 
program, NIDCAP, and massage, among others) have been widely studied with some 
evidence for benefit, although it is uncertain which elements beyond enhanced holding, 
touching and parent involvement are keys to improved neurodevelopment.41 The extent 
to which term neonates with brain injury may benefit from a similar approach is not 
known, however early involvement of physical and occupational therapy and parent 
education about enriched environments is warranted42, and moreover, such 
interventions can provide valuable assessment information.  
Conclusions and Future Directions 
 
This review has described evolution of the NICN (or, Neuro-NICU), a model of care that 
is becoming more widely adopted at many regional centers of excellence. In the NICN of 
the future, new technologies will enhance clinical protocols and precision medicine for 
infants at risk for neurological injury. These include (1) functional MRI, (2) continuous 
neurophysiological assessment with machine learning tools to make bedside EEG 
reading more robust and accessible, and (3) whole genomic approaches to rapidly 
diagnose patients with neurogenetic or severe metabolic conditions. Genome diagnosis 
is particularly relevant to consider in the context of neonatal seizures. Indeed, we expect 
genome sequencing will become routine to stratify patients for appropriate drug 
treatments, such as oxcarbazepine or carbamazepine for KCNQ2 mutation causing 
encephalopathy.43  
The NICN model is generally considered by clinicians to be an advance in bedside care. 
The NICN model empowers staff to use the latest tools in the treatment of infants at risk 
for neurological injury. We have seen encouraging data from hypothermia trials and new 
neuroprotective trials are likely to provide additional treatments. An added substantial 
benefit is providing comprehensive information for counseling families that face difficult 
decisions. However, the big test question for the NICN/Neuro-NICU model is: Does it 
improve long-term outcomes? The answer will come from long term follow up and 
therefore a decision to develop a NICN program should ideally be matched with a 
commitment to follow children through school age and beyond to definitively show this 
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